Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinical Trial Enrollment

- PMLiVE

Draftfcb New York announces internal re-shuffle

Dana Maiman to focus on Draftfcb Healthcare as agency steps up its healthcare offering

EISAI

Eisai expands into South Africa

Files Halaven and Fycompa for approval

- PMLiVE

Succinct forms market access partnership with Royal Marsden

Agency aims is to tackle non-financial issues relating to new medicines

- PMLiVE

Boehringer launches COPD patient consultation app for HCPs

Extends reach of the calculator tools on its COPD Exchange website

- PMLiVE

Endo to collaborate with India-based CRO GVK Biosciences

Will develop small molecule against undisclosed target in pain

- PMLiVE

Kantar Health appoints two senior researchers

Dr Theano Anasta and Svetlana Gogolina join research firm

Lonafarnib: promising results in first-ever trial for progeria

Treatments for progeria are limited but lonafarnib and FTIs as a class have given renewed hope for children with the condition

New marcomms agency opens in London’s Tech City

Couch is developing a client list from across pharma, private and public sectors

- PMLiVE

France investigates Bayer’s acne drug Diane 35 after deaths

Linked to blood clots in women

- PMLiVE

GSK forms Indian vaccine research joint venture

Will work with local firm Biological E on six-in-one combination vaccine

- PMLiVE

Takeda gets FDA approval for alogliptin franchise in diabetes

Comprises Nesina, Oseni and Kazano

- PMLiVE

NICE metrics flawed and should not be used, says EU study

ECHOUTCOME criticises used of quality adjusted life years in HTAs

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links